Contura | Hydrogels for life
  • About
    • Technology
    • Facility
    • History
    • Team
  • Therapeutic areas
    • Orthopaedics
    • Aesthetics
    • Animal Health
  • News
  • Contact us
  • Careers
  • en English
    da Danishen Englishfi Finnishfr Frenchde Germanis Icelandicno Norwegianes Spanishsv Swedish

Month: June 2019

Commencement of a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis

Posted on 15 June 2019 | by Originmeister | Leave a Comment on Commencement of a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis

Recent Posts

  • CONTURA ANNOUNCES NEW CEO TO ACCELERATE FUTURE GROWTH
  • Contura sells Bulkamid® to Axonics Modulation Technologies, Inc
  • Bulkamid: one year anniversary of FDA approval in the United States
  • Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis
  • Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.

Recent Comments

  • A WordPress Commenter on Speciality European Pharma acquires Contura A/S

Archives

  • November 2021
  • February 2021
  • January 2021
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • June 2019
  • May 2018
  • January 2018
  • July 2017
  • April 2017
  • February 2017
  • December 2016
  • May 2016
  • September 2015
  • July 2015
  • December 2014
  • May 2013
  • April 2013

Categories

  • Animal Health
  • Bulkamid
  • Contura
  • Orthopaedics

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Aquamid and Arthrosamid are registered trademarks of Contura International A/S.
Contura Vet is a registered trademark of Contura Vet Ltd.
Cystistat is a registered Trademark of Mylan Institutional Ltd.
Privacy Notice
© copyright 2022 Contura International Ltd.